Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2025 of $1.24 per share on the company’s common stock. The dividend is payable on March 4, 2025 to shareholders of record at the close of business on February 18, 2025. The ex-dividend date is February 18, 2025.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

Media contact: media-relations@its.jnj.com Investor contact: investor-relations@its.jnj.com

Johnson and Johnson (NYSE:JNJ)
過去 株価チャート
から 12 2024 まで 1 2025 Johnson and Johnsonのチャートをもっと見るにはこちらをクリック
Johnson and Johnson (NYSE:JNJ)
過去 株価チャート
から 1 2024 まで 1 2025 Johnson and Johnsonのチャートをもっと見るにはこちらをクリック